Drugs

Environmental Monitoring in Compounding

Number of lessons: 4
Introduction to FDA’s Office of Trade and Global Partnerships

Number of lessons: 7
Rx Drug Promotion and the Clear, Conspicuous, and Neutral Final Rule

Number of lessons: 3
OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2024 User Fees and Registration

Number of lessons: 3
OSIS Workshop: CDER Bioavailability/Bioequivalence Study Sites and Inspections of Good Laboratory Practice

Number of lessons: 9
FDA Regulatory Education for Industry (REdI) 2024 Conference – Plenary and Drugs Track

Number of lessons: 16